Jump to main content
Topic: Drug Pricing
-
Medicare Part B Premium Dynamics Explained
Read More
-
Evaluating Industry’s Drug Pricing Claims
Read More
-
Production Plus Profit Pricing (P-quad) FAQ
Read More
-
What A Waste! The National Academy Of Medicine’s Report On Oversized Vials Of Expensive Drugs
Read More
-
Medicare Must Study Unproven, Expensive Alzheimer’s Drug
Read More
-
Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy
Read More
-
Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle
Read More
-
The Drugs at the Heart of Our Pricing Crisis
Read More
-
Biosimilars: Market Changes do not equal policy success
Read More
-
Ethics of Clinical Trials to Evaluate Biosimilars
Read More